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Abstract
Purpose The aim of this study was to evaluate whether the addition of brain CT imaging data to a model incorporating clinical
risk factors improves prediction of ischemic stroke recurrence over 5 years of follow-up.
Methods A total of 638 patients with ischemic stroke from three centers were selected from the Dutch acute stroke study
(DUST). CT-derived candidate predictors included findings on non-contrast CT, CT perfusion, and CT angiography. Five-
year follow-up data were extracted frommedical records.We developed amultivariable Cox regressionmodel containing clinical
predictors and an extended model including CT-derived predictors by applying backward elimination. We calculated net
reclassification improvement and integrated discrimination improvement indices. Discrimination was evaluated with the
optimism-corrected c-statistic and calibration with a calibration plot.
Results During 5 years of follow-up, 56 patients (9%) had a recurrence. The c-statistic of the clinical model, which contained
male sex, history of hyperlipidemia, and history of stroke or transient ischemic attack, was 0.61. Compared with the clinical
model, the extendedmodel, which contained previous cerebral infarcts on non-contrast CT and Alberta Stroke Program Early CT
score greater than 7 on mean transit time maps derived from CT perfusion, had higher discriminative performance (c-statistic
0.65, P = 0.01). Inclusion of these CT variables led to a significant improvement in reclassification measures, by using the net
reclassification improvement and integrated discrimination improvement indices.
Conclusion Data from CT imaging significantly improved the discriminatory performance and reclassification in predicting
ischemic stroke recurrence beyond a model incorporating clinical risk factors only.
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Background
Recurrent stroke accounts for approximately a quarter of all
strokes that occur and has important implications for the long-
term outcome of patients [1]. The 1-year incidence of recur-
rent ischemic stroke has been estimated to range from 8 to
14% [2, 3]. The risk estimation of recurrent ischemic stroke
can be achieved by using prediction models.
Many clinical predictors for recurrent ischemic stroke have
been investigated. Strong evidence was established for a lim-
ited number of factors, which include stroke prior to the index
stroke and stroke subtype [4]. Other factors such as age, sex,
hypertension, diabetes mellitus, hyperlipidemia, smoking, his-
tory of myocardial infarction, history of atrial fibrillation, and
history of peripheral artery disease have been suggested as
predictors of recurrent ischemic stroke in some studies, but
not in others [4].
CT is often the imaging modality of choice for diagnos-
ing acute ischemic stroke mostly due to high availability
and lack of contraindications [5]. Previously identified im-
aging predictors for recurrent ischemic stroke include acute
ischemia on non-contrast CT (NCCT), occlusion or steno-
sis on CT angiography (CTA), and poor collateral supply
on CTA [6, 7]. In addition, magnetic resonance imaging
(MRI)–derived predictors such as multiple ischemic lesions
are shown to have added value to clinical models [4, 8, 9].
Clinical prediction models have been summarized in a
systematic review and meta-analysis [10]. The discrimina-
tive performance of these models was moderate [10]. Most
models are developed for predicting recurrences of ische-
mic stroke not longer than 90 days or 1 year after the initial
stroke, whereas ischemic stroke may recur up to 5 years
after the initial stroke and beyond [11]. To our knowledge,
the only model that was developed to predict 5-year ische-
mic stroke recurrence was developed in young stroke pa-
tients. Prediction of 5-year recurrent stroke in adult patients
has not been studied before, and the added value of CT-
derived predictors is unknown. Therefore, we sought to
develop a model incorporating clinical risk factors for
predicting 5-year recurrent ischemic stroke in patients with
ischemic stroke and to determine whether adding CT-
derived predictors improves prediction of recurrent ische-
mic stroke over 5 years of follow-up.
Methods
Study population
All patients participated in the Dutch acute stroke study
(DUST), a prospective multicenter observational cohort study
in The Netherlands. The DUST was designed to assess the
prognostic value of CT perfusion (CTP) and CTA in
predicting clinical outcome after 90 days, in addition to patient
characteristics and NCCT findings. A detailed description of
the design and baseline characteristics of the participants has
been described elsewhere [12, 13]. The study was approved
by the medical ethics committee of the University Medical
Center Utrecht, The Netherlands.
The current study is based on the three largest DUST cen-
ters: University Medical Center Utrecht; Leiden University
Medical Center; and St. Antonius Hospital, Nieuwegein.
Patients were enrolled between 2009 and 2013. Additional
5-year follow-up data were collected by evaluating medical
records in June 2018. From the original 766 patients enrolled
in the three selected DUST centers, imaging data were incom-
plete for 38 patients. Additionally, we excluded 90 patients
without a diagnosis of ischemic stroke at baseline. The re-
maining sample included 638 patients.
Baseline assessments
The following baseline data were collected: demographics
(age and sex), pre-stroke modified Rankin scale (mRS), char-
acteristics of the index event (National Institutes of Health
stroke scale [NIHSS], Trial of ORG 10172 in Acute Stroke
Treatment [TOAST] classification), time from symptom onset
to CT scan, intravenous thrombolysis, endovascular treat-
ment, and vascular risk factors [14]. Imaging data were ex-
tracted from the DUST database. In the DUST, the acquired
images were assessed by an observer with at least 5 years of
experience in neurovascular imaging (from a pool of three
observers) [12]. The observers were blinded for clinical infor-
mation (except for side of symptoms), follow-up imaging, and
clinical outcomes. Imaging data includedNCCT findings such
as hyperdense vessel sign and Alberta Stroke Program Early
CT score (ASPECTS) of either the anterior or posterior circu-
lation. CTA findings included the presence of occlusion, clot
burden score (CBS), collateral score (CS), and internal carotid
artery (ICA) stenosis [15–17]. Furthermore, ASPECTS was
determined on cerebral blood volume and mean transit time
maps, which were derived from CTP [18]. The CTP coverage
was adjusted to the clinical indication [12]. The CTP coverage
ranged from 40 mm to full brain coverage including at least
both ASPECTS levels. In case a posterior circulation stroke
was expected, the CTP coverage was adjusted to cover all
three pc-ASPECTS levels.
Candidate predictors
All candidate predictors were selected based on the results of
two systematic literature reviews [4, 10]. Demographic factors
included age and sex. Lifestyle factors included current
smoking. Clinical characteristics included the NIHSS score
(continuous) on admission and the TOAST classification.
Health variables included hypertension, diabetes mellitus,
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hyperlipidemia, history of myocardial infarction, history of
atrial fibrillation, history of peripheral artery disease, and his-
tory of transient ischemic attack (TIA) or ischemic stroke.
Imaging characteristics included previous cerebral infarcts
on NCCT, hyperdense vessel sign on NCCT, ICA stenosis >
70% on CTA, collateral score (poor versus good) on CTA,
and ASPECTS (> 7 versus ≤ 7) on cerebral blood volume and
mean transit time maps [17, 19, 20].
Recurrent ischemic stroke
Follow-up data were based on hospital visits (e.g., follow-up
visits or admissions) or communications (e.g., telephone or
correspondence) and were extracted from medical records. If
follow-up data were missing, the patient was censored in this
study at the time of the last visit or communication.
The primary outcome was recurrent ischemic stroke, which
was defined as a clinical event of sudden onset with new
neurological deficits that persisted for more than 24 h and
was not caused by another diagnosis than ischemic stroke.
Statistical analysis
Hazard ratios and 95% confidence intervals were calculated
for candidate predictors of recurrent ischemic stroke by
performingmultivariable Cox regression analyses. We plotted
Schoenfeld residual plots to check the proportional hazards
assumption, which was not violated.
Two models were developed: model 1 included clinical
predictors and model 2 included clinical and imaging predic-
tors. First, the clinical model was developed applying back-
ward elimination to the model with all the clinical candidate
predictors. The full model containing all candidate predictors
was then simplified by performing backward elimination
based on a P value threshold of 0.1. For model 2, the candidate
imaging predictors were added to the final clinical model and
the described process of backward elimination was repeated.
To prevent removal of the clinical predictors, the clinical pre-
dictors were forced into the model. Model improvement was
evaluated by calculating the continuous net reclassification
improvement (NRI) and 95% confidence interval using the
Kaplan–Meier method and 1000 bootstrap samples [21, 22].
NRI is based on reclassification of patients with or without the
outcome and increases as the patients with the outcome are
reclassified as having a high risk or the patients without the
outcome are reclassified as having a low risk [21]. The im-
provement in discrimination slopes was evaluated with the
measure of integrated discrimination improvement (IDI)
[21]. Model improvement was also evaluated with the likeli-
hood ratio test.
Optimism of the clinical and extended models was evalu-
ated with 1000 bootstrap samples. Global shrinkage of the
model was done with the jackknife method [23]. Finally,
discrimination and calibration of the optimism-correctedmod-
el were assessed with the c-statistic and the calibration plot
and its slope. Statistical analysis was performed with packages
survival, rms, nricens, and survIDINRI in R version 3.5.0.
This study was performed in accordance with the TRIPOD
Checklist for Prediction Model Development and Validation
[24].
Results
Of the 638 patients with stroke at baseline, 56 (9%) had a
recurrent ischemic stroke over the 5 years of follow-up.
Baseline characteristics are shown in Table 1. Comparison
of the baseline characteristics of our study population with
all remaining DUST participants is shown in Supplemental
Table I.
Model building
The main clinical predictors of ischemic stroke recurrence
were male sex, history of hyperlipidemia, and history of either
stroke or TIA (Table 2). The c-statistic of the clinical model,
which contained male sex, history of hyperlipidemia, and his-
tory of stroke or transient ischemic attack, was 0.61.
Compared with the clinical model, the extended model, which
contained previous cerebral infarcts on non-contrast CT and
ASPECTS greater than 7 on mean transit time maps derived
from CTP, had higher discriminative performance (c-statistic
0.65, P = 0.01).
The NRI for the recurrence group was 0.40 (95% CI −
0.04–0.73) and 0.04 (95% CI − 0.13–0.54) for the non-
recurrence group. Taken together, the total NRI was signifi-
cant (0.44, 95% CI 0.14–0.74). The discrimination slope also
improved significantly (IDI 0.03, 95% CI 0.01–0.09).
The calibration plots are shown in Fig. 1. According to the
slopes of the clinical (0.70) and the extended (0.72) models,
the models were reasonably calibrated.
Discussion
In this study, addition of two CT imaging variables
(previous cerebral infarcts on NCCT and ASPECTS on
mean transit time maps derived from CTP) to the clin-
ical model resulted in a significant improvement in dis-
crimination performance for ischemic stroke recurrence
over 5-year follow-up.
CT is often performed in patients with ischemic stroke as
CT has some advantages over MRI in the acute stroke set-
ting such as the short acquisition time, patient compatibil-
ity, costs, and availability. Besides diagnostic purposes,
findings on admission CT can be used for prognostic
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purposes in patients with acute ischemic stroke. For in-
stance, several studies investigated the value of CT findings
on predicting clinical outcome after ischemic stroke [13,
25]. The added value of predictors derived from CTP and
CTA for predicting clinical outcome after 3 months was
limited in the DUST dataset [13]. A previous study showed
that prediction of recurrent ischemic stroke at 90 days was
significantly improved by adding MRI-derived predictors
such as multiple infarcts and involvements of multiple vas-
cular territories to a clinical model [8]. In addition, similar
MRI-derived predictors were identified as being predictive
of recurrent ischemic stroke during a 2-year follow-up [9].
Table 1 Baseline characteristics
stratified by recurrence of
ischemic stroke over 5 years of
follow-up
Characteristic Recurrence (n = 56) No recurrence (n = 582)
Age, mean ± SD 68 ± 12 67 ± 14
Male sex, n (%) 41 (73) 324 (56)
mRS ≥ 3 before stroke, n (%) 1 (2) 43 (7)
Admission NIHSS, median (Q1–Q3) 4 (3–7) 6 (3–12)
Posterior circulation infarct, n (%) 11 (20) 79 (14)
Intravenous thrombolysis, n (%) 30 (54) 360 (62)
Endovascular treatment, n (%) 1 (2) 40 (7)
Medical history
Hypertension, n (%) 34 (62) 285 (49)
Diabetes mellitus, n (%) 10 (18) 74 (13)
Hyperlipidemia, n (%) 29 (52) 161 (28)
Smoking currently, n (%) 15 (29) 178 (33)
Former smoking, n (%) 22 (42) 154 (28)
Never smoked, n (%) 15 (29) 213 (39)
Atrial fibrillation, n (%) 8 (15) 79 (14)
Anticoagulant medication, n (%) 12 (21) 82 (14)
History of stroke or TIA, n (%) 22 (39) 114 (20)
History of MI, n (%) 10 (18) 65 (11)
History of PAD, n (%) 4 (7) 30 (5)
Imaging findings
Previous cerebral infarcts on NCCT, n (%) 24 (43) 170 (29)
Hyperdense vessel sign, n (%) 5 (9) 123 (21)
Early signs of ischemia on NCCT, n (%) 13 (23) 160 (27)
Perfusion deficit present on CTP, n (%) 27 (51) 383 (68)
CBV ASPECTS, median (Q1–Q3) 10 (9–10) 10 (7–10)
CBV ASPECTS ≤ 7, n (%) 5 (9) 143 (25)
MTT ASPECTS, median (Q1–Q3) 10 (8–10) 8 (4–10)
MTT ASPECTS ≤ 7, n (%) 10 (19) 251 (45)
ICA stenosis > 70% on CTA 12 (22) 125 (22)
Occlusion on CTA, n (%) 22 (39) 329 (57)
Clot burden score, median (Q1–Q3) 10 (9–10) 10 (7–10)
Poor collateral score, n (%) 6 (11) 102 (18)
TOAST classification
Large artery atherosclerosis, n (%) 18 (32) 185 (32)
Cardioembolism, n (%) 5 (9) 114 (20)
Small-vessel disease, n (%) 11 (20) 54 (9)
Other, n (%) 4 (7) 49 (8)
Unknown, n (%) 18 (32) 180 (31)
SD, standard deviation; mRS, modified Rankin scale; NIHSS, National Institutes of Health stroke scale; TIA,
transient ischemic attack; MI, myocardial infarction; PAD, peripheral artery disease; NCCT, non-contrast CT;
CTP, CT perfusion;CBV, cerebral blood volume;ASPECTS, Alberta Stroke ProgramEarly CT score;MTT, mean
transit time; ICA, internal carotid artery
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However, the added value of CT-derived predictors has
never been investigated for predicting recurrent ischemic
stroke beyond 2 years. In this study, we showed that recur-
rence risk estimation can be significantly improved by
adding CT-derived predictors to a model incorporating
clinical predictors.
Although stroke subtype was a significant predictor of recur-
rent ischemic stroke in previous studies, this predictor did not
Table 2 Effect estimates of the
full and simplified clinical models
and the extended model for
predicting recurrent ischemic
stroke








Age > 65 1.5 (0.8–2.8) 1.3 (0.7–2.3) 1.2 (0.7–2.2) -
Male sex 1.7 (0.9–3.2) 1.9 (1.1–3.5) 1.7 (0.9–3.2) 1.8 (0.98–3.3)
Hypertension 1.0 (0.5–1.8) - - -
Diabetes 0.9 (0.4–2.0) - - -
Current smoking 0.7 (0.4–1.5) - - -
History of hyperlipidemia 2.0 (1.01–3.9) 1.7 (0.98–3.0) 1.6 (0.9–2.9) 1.8 (1.03–3.2)
History of stroke/TIA 2.1 (1.1–3.9) 2.4 (1.3–4.1) 2.1 (1.1–3.8) 2.0 (1.1–3.6)
History of MI 0.9 (0.4–2.1) - - -
History of AF 0.9 (0.4–2.0) - - -
History of PAD 1.0 (0.3–3.3) - - -
NIHSS ≥ 7 0.7 (0.4–1.4) - - -
Lacunar stroke (TOAST) 0.6 (0.3–1.2) 0.6 (0.3–1.1) 0.6 (0.3–1.3) -
Previous cerebral infarct
on NCCT
1.5 (0.9–2.7) 1.5 (0.9–2.7)
Hyperdense vessel sign on
NCCT
0.7 (0.2–2.3) -
CBV ASPECTS > 7 1.1 (0.3–4.2) -
MTT ASPECTS > 7 2.8 (0.97–8.0) 2.3 (1.2–4.7)
ICA stenosis > 70% on
CTA
1.8 (0.9–3.8) -
Occlusion on CTA 0.8 (0.4–1.6) -





Calibration slope 0.70 0.72
CI, confidence interval; TIA, transient ischemic attack; NCCT, non-contrast CT; CBV, cerebral blood volume;
ASPECTS, Alberta Stroke Program Early CT score; MTT, mean transit time; ICA, internal carotid artery
Fig. 1 Calibration plot for the clinical model (a) and the extended model (b) containing clinical and CT-derived predictors. A calibration slope of 1.0
indicates perfect calibration (dotted line)
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have added value to the clinical prediction model in our study
population [4]. The stroke etiology was determined using the
TOAST classification [14]. Determination of the stroke etiology
often requires extensive diagnostic work-up and can sometimes
only be accurately determined during a follow-up period after
the stroke, whereas immediate recurrence prediction after the
index event is desirable [26]. In this study, the TOAST classifi-
cation was determined during the initial admission phase. As
follow-up studies for determining the final stroke etiology were
not routinely taken into account, the cause of the stroke
remained unknown for 31% of the cases. Therefore, the results
from this particular analysis need to be interpreted with caution.
Future studies should elucidate whether stroke subtype has
added value to long-term prediction of recurrent stroke.
The added value of previous cerebral infarcts onNCCT to a
history of either stroke or TIA can be explained by the fact that
brain ischemia may occur without the patient noticing, which
is called a silent brain infarction. The association between
silent brain infarction and future stroke has been established
before, but it has never been related to recurrent ischemic
stroke [27]. Whether the patient has had a previous ischemic
stroke or TIA is usually evaluated by history taking. However,
it is possible that ischemic brain damage is present, although
the patient has not experienced any stroke symptoms. This is a
typical example of how CT imaging has added prognostic
value to clinical assessments such as history taking.
Intuitively, prediction models will be more reliable if they
include predictors that are already well-established risk factors
for recurrent stroke. We found that poor collaterals did not
seem to be an important predictor for recurrent stroke. This
finding does not mean that poor collateral is not a risk factor
for recurrent stroke by itself, but, instead, this factor has no
added value to the prediction of recurrent stroke beyond the
other predictors used in our risk prediction model. An expla-
nation for this finding might be the lack of power due to the
small number of patients with poor collaterals. This finding
needs verification in a more balanced population.
The observed association between higher ASPECTS on
mean transit time maps derived from CTP and increased re-
currence risk is surprising, because it implies that patients with
smaller areas of ischemia and/or involvement of less
ASPECTS regions face a higher risk of recurrence compared
with patients with greater areas of ischemia and/or involve-
ment of more ASPECTS regions. We were not able to distin-
guish between the infarct size and the multiplicity of the in-
farct as these data were not routinely collected in the DUST.
Additional studies are warranted to confirm this remarkable
finding and to assess its relation to infarct size, multiplicity,
and etiology. An advantage of using ASPECTS is that it can
be accurately graded in the acute stroke phase and that it can
be instantly used for prediction purposes. Although
ASPECTS has been initially developed for NCCT assess-
ments, it can also be applied to other CT modalities such as
CTP [15, 28]. In this study, the dichotomized measure of
ASPECTS had added value to the clinical prediction model,
making it a promising tool for recurrence prediction purposes.
This finding however needs verification in a larger study with
prospective outcome evaluation.
In this study, we showed that recurrence prediction after is-
chemic stroke can be improved by using imaging information in
addition to clinical information. However, even after the model
was improved, the performance was still moderate. Some steps
need to be taken before a model that predicts recurrent ischemic
stroke can be used in routine stroke care. First, studies may look
for additional predictors (e.g., derived from imaging) to see if a
clinically relevant improvement can be achieved. For example,
current studies are also focusing on including the heart in the
stroke admission scan to improve the early diagnosis of cardio-
embolic causes. Preferably, the found predictors such as
ASPECTS onMTTmaps should be validated in a separate study
cohort. Second, once a model with a sufficiently high perfor-
mance is developed, it needs to be validated in other cohorts.
Third, ideally, the impact of the model needs to be quantified
in a randomized controlled trial. In this way, the prognostic mod-
el may guide treatment decisions and therefore affect patient
outcomes. This study contributes to the process of finding an
optimal model for recurrence prediction.
Strengths of this study were the long-term follow-up and the
selection of candidate predictors, whichwere based on literature.
In this way, we avoided selecting predictors purely on signifi-
cant P values. In addition, predictor information was collected,
prospectively leading to a minimal number of missing values. A
limitation of this study was the retrospective collection of
follow-up data, which could have induced underestimation of
the outcome prevalence. This could have influenced our results
in case certain associations are related to the loss of follow-up.
For instance, recurrences, which were recorded in another hos-
pital than the hospital of the index stroke, were missed. We do
not believe that this has happened often, as most patients return
to their own hospital for follow-up visits. Still, the observed
prevalence is in line with previous studies, but studies with
prospective follow-up are needed to verify our findings. The
number of outcomes was relatively small, which was also a
limitation of this study. Heart failure was not collected as a
potential predictor in this study, whereas it showed to be of
predictive value in previous studies [29, 30]. However, with
less than sixty recurrences, we were not allowed to add more
than five predictors to our extendedmodel. Selecting only three
out of fourteen DUST centers contributed to this limitation, but
acquiring follow-up data from the other DUST centers was not
deemed feasible. Studying larger cohorts may allow more pre-
dictors into the final model. Instead of improving a previously
developed model, we had to create our own clinical model that
best fitted our data. A drawback of this method is that our
clinical model needs validation in other studies, whereas a pre-
viously developed model has already been validated.
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In conclusion, clinical models for predicting long-term re-
currence after ischemic stroke have moderate performance
and can be improved by adding CT-derived predictors.
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